EGFR and lung cancer: Restoration of the TUSC2/FUS1 tumor suppressor gene, which also functions as a multikinase inhibitor, enhances killing of EGFR wild type human lung cancer cells by the EGFR tyrosine kinase inhibitor erlotinib4, 6, 19.